Current HIV Research
Volume 19, 6 Issues, 2021
ISSN: 1873-4251 (Online)
ISSN: 1570-162X (Print)
This journal supports open access
ISSN: 1873-4251 (Online)
ISSN: 1570-162X (Print)
This journal supports open access
Contents
Current HIV Research, Volume 14 - Number 1
Editorial Open Access
Perspectives of Genome-Editing Technologies for HIV Therapy
, 14(1): 2 - 8Hirotaka Ebina, Peter Gee and Yoshio Koyanagi
DOI: 10.2174/1570162X13666150807105718
Perspectives of Genome-Editing Technologies for HIV Therapy
Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses
, 14(1): 9 - 23Maxime Veillette, Jonathan Richard, Marzena Pazgier, George K. Lewis, Matthew S. Parsons and Andres Finzi
DOI: 10.2174/1570162X13666150827093449
Role of HIV-1 Envelope Glycoproteins Conformation and Accessory Proteins on ADCC Responses
Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment
, 14(1): 24 - 36Olga S. Latinovic, Jian Zhang, Yutaka Tagaya, Anthony L. DeVico, Timothy R. Fouts, K. Schneider, Joseph R. Lakowicz, Alonso Heredia and Robert R. Redfield
DOI: 10.2174/1570162X13666150909145150
Synergistic Inhibition of R5 HIV-1 by the Fusion Protein (FLSC) IgG1 Fc and Maraviroc in Primary Cells: Implications for Prevention and Treatment
Microarray Analysis Reveals Altered Lipid and Glucose Metabolism Genes in Differentiated, Ritonavir-Treated 3T3-L1 Adipocytes
, 14(1): 37 - 46Cathriona R. Loonam, Sandra D. O'Dell, Paul A. Sharp and Anne Mullen
DOI: 10.2174/1570162X13666150806110238
Microarray Analysis Reveals Altered Lipid and Glucose Metabolism Genes in Differentiated, Ritonavir-Treated 3T3-L1 Adipocytes
Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy
, 14(1): 47 - 53Hassen S. Wollebo, Bianca Cotto, Radhika Adiga, Dianne Langford and Martyn K. White
DOI: 10.2174/1570162X1401151102125319
Expression of Signaling Molecules in Progressive Multifocal Leukoencephalopathy
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics
, 14(1): 54 - 60Andrea Calcagno, Chiara Montrucchio, Amedeo Capetti, G. Guaraldi, G. Cenderello, Leonardo Calza, M. Lanzafame, Letizia Marinaro, M.C. Tettoni, Laura Trentini, Aantonio D'Avolio, Giovanni Di Perri and Stefano Bonora
DOI: 10.2174/1570162X13666150929112135
Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
, 14(1): 61 - 70Leonardo Calza, Eleonora Magistrelli, Ilaria Danese, Vincenzo Colangeli, Marco Borderi, Isabella Bon, Maria Carla Re, Rita Mancini, Matteo Conti, Roberto Motta and Pierluigi Viale
DOI: 10.2174/1570162X1401151102143222
Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort
, 14(1): 71 - 79Anita Shet, N. Kumarasamy, Selvamuthu Poongulali, Suresh Shastri, Dodderi Sunil Kumar, Bharath B. Rewari, Karthika Arumugam, Jimmy Antony, Ayesha De Costa and George D’Souza
DOI: 10.2174/1570162X13666150825123750
Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort
Editor-in-Chief
Yuntao Wu
National Center for Biodefense and Infectious Diseases
School of Systems Biology
George Mason University
Manassas, VA
(USA)
Biography
National Center for Biodefense and Infectious Diseases
School of Systems Biology
George Mason University
Manassas, VA
Biography
Biography of Yuntao Wu
Dr. Yuntao Wu is a professor at the National Center for Biodefense and Infectious Diseases, George Mason University, Manassas, Virginia, USA. He received his Ph.D. from the Department of Microbiology and Immunology at Queen’s University, Kingston, Ontario, Canada, and his postdoctoral training at NIH, Bethesda, Maryland, USA. Dr. Wu studies HIV infection of blood CD4 T cells and macrophages (Science, 2001, 293:1503-6), mainly focusing on the role of chemokine- and HIV-1-mediated G-protein signaling and actin dynamics in HIV infection and pathogenesis (Cell, 2008, 134,782; Science Advances, 2019, 5:1,aat7911). Currently, his lab also studies the mechanisms of PSGL-1 restriction of HIV infection (Nature Microbiology, 2019, 4:813-25).
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Advertisement
Webmaster Contact: info@benthamscience.net